Alterations in circulating vasoactive substances in the critically ill —a comparison between survivors and non-survivors

ObjectiveRegulation of circulatory homeostasis is based on several factors including various circulating vasoactive substances. Whether these regulators differ between survivors and non-survivors was investigated in critically ill patients.DesignProspective study.SettingClinical investigation on a surgical intensive care unit of an university hospital.Patients60 consecutive patients suffering from trauma (n=21) or postoperative complications (n=39) were studied prospectively. The patients were divided into survivors (n=27) and non-survivors (n=33). Therapy was adjusted to the standards of modern intensive care management by physicians who were not involved in the study.Measurements and resultsEndothelin-1, atrial natriuretic peptide (ANP), vasopressin, renin, and catecholamine (epinephrine, norepinephrine) plasma levels were measured from arterial blood samples using radioimmunoassay (RIA) or high-pressure liquid chromatography (HPLC) technique on the day of admission to ICU and during the following 5 days. Various hemodynamic parameters were also monitored during that period. The non-survivors showed elevated pulmonary artery pressure (PAP: 34.1±5.4 mmHg) and pulmonary capillary wedge pressure (PCWP: 20.3±7.3 mmHg) already at the beginning of the study. Cardiac index (CI) did not differ among the groups, whereas right ventricular ejection fraction (RVEF) decreased in the non-survivors. PaO2/FIO2 decreased only in the non-survivors, whereas VO2 increased in the survivors (from 246±48 to 331±43 ml/min). Plasma levels of renin (from 206±40 to 595±81 pg/ml) and vasopressin (from 5.78±0.82 to 7.97±0.69 pg/ml) increased significantly in the non-survivors. Epinephrine and norepinephrine plasma concentrations were elevated in the non-survivors already at baseline and tremendously increased in these patients during the following days. ANP plasma levels significantly increased also only in the non-survivors (from 188±63 to 339±55 pg/ml) (p<0.05). Endothelin-1 decreased in the survivors, whereas it significantly increased in the non-survivors (from 3.62±0.68 to 9.37±0.94 pg/ml) during the study period (p<0.05). Analyses of co-variance revealed overall no significant correlation between circulating vasoactive substances and hemodynamics.ConclusionsSystemic and regional regulators of the circulation were markedly changed by critical illness. In survivors, these regulators almost normalized within the study period of 5 days, whereas in non-survivors these alterations were even aggravated. It can only be speculated whether these regulator systems were influenced by activation of various mediator systems or whether they themselves influenced the negative outcome in the non-survivors.

[1]  J. Whitworth,et al.  ACTIVE AND INACTIVE RENIN IN CRITICALLY ILL PATIENTS , 1985, Clinical and experimental pharmacology & physiology.

[2]  W C Shoemaker,et al.  Clinical trial of survivors' cardiorespiratory patterns as therapeutic goals in critically ill postoperative patients. , 1982, Critical care medicine.

[3]  R. Hall,et al.  Vasoactive hormones in endotoxin shock: A comparative study in cats and dogs , 1971, The Journal of physiology.

[4]  Jones Sb,et al.  Dose- and time-dependent changes in plasma catecholamines in response to endotoxin in conscious rats. , 1989 .

[5]  J. Dave,et al.  Circulating atrial natriuretic peptides in conscious rats: regulation of release by multiple factors. , 1986, Science.

[6]  P. Mair,et al.  Endothelin and big endothelin concentrations in injured patients. , 1991, The New England journal of medicine.

[7]  N. Braunwald,et al.  Prosthetic reconstruction of the mitral valve. Applications in the correction of mitral stenosis and mitral regurgitation. , 1963, Progress in cardiovascular diseases.

[8]  Sadao Kimura,et al.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.

[9]  P. Killworth Adrian Edmund Gill (1937–1986) , 1986, Nature.

[10]  E. Weitzberg,et al.  Elevated plasma levels of endothelin in patients with sepsis syndrome. , 1991, Circulatory shock.

[11]  P. Vanhoutte,et al.  Hypoxia releases a vasoconstrictor substance from the canine vascular endothelium. , 1985, The Journal of physiology.

[12]  D. Brackett,et al.  Mechanisms of Impaired Cardiac Function by Vasopressin , 1980, Annals of surgery.

[13]  B. Brenner,et al.  Endothelium-dependent vascular responses. Mediators and mechanisms. , 1989, The Journal of clinical investigation.

[14]  Brackett Dj,et al.  Release of vasoactive hormones and circulatory changes in shock. , 1983 .

[15]  P. Hickey,et al.  Hormonal-metabolic stress responses in neonates undergoing cardiac surgery. , 1990, Anesthesiology.

[16]  E. Hartter,et al.  RADIOIMMUNOASSAY OF ENDOTHELIN , 1989, The Lancet.

[17]  K. Voigt,et al.  Patterns of endocrine secretion during sepsis. , 1989, Progress in clinical and biological research.

[18]  S. Atlas Atrial natriuretic factor: a new hormone of cardiac origin. , 1986, Recent progress in hormone research.

[19]  D. Ganten,et al.  Release and regulation of atrial natriuretic peptide (ANP). , 1987, European heart journal.

[20]  C. Johnston,et al.  Plasma vasopressin and human neurophysins in physiological and pathological states associated with changes in vasopressin secretion. , 1979, The Journal of clinical endocrinology and metabolism.

[21]  L. Thijs Transport and Consumption of Oxygen in Septic Shock , 1988 .

[22]  J. Vane,et al.  Regulatory functions of the vascular endothelium. , 1990, The New England journal of medicine.

[23]  A. Whorton,et al.  Determination of immunoreactive endothelin in medium from cultured endothelial cells and human plasma. , 1989, Biochemical and biophysical research communications.

[24]  T. Inagami,et al.  Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. , 1989, Biochemical and biophysical research communications.

[25]  J. Madwed,et al.  Cardiovascular, renal, and endocrine responses to intravenous endothelin in conscious dogs. , 1988, The American journal of physiology.

[26]  A. Krstulović,et al.  Investigations of catecholamine metabolism using high-performance liquid chromatography: analytical methodology and clinical applications. , 1982, Journal of chromatography.

[27]  T. Lüscher,et al.  Endothelin: systemic arterial and pulmonary effects of a new peptide with potent biologic properties. , 1992, The American review of respiratory disease.

[28]  P. Needleman,et al.  Atriopeptin: a cardiac hormone intimately involved in fluid, electrolyte, and blood-pressure homeostasis. , 1986, The New England journal of medicine.

[29]  W. Shoemaker,et al.  Physiologic responses to massive intraoperative hemorrhage. , 1980, Archives of surgery.

[30]  M. Boarder,et al.  Characterization of Endothelin‐1 Stimulation of Catecholamine Release from Adrenal Chromaffin Cells , 1989, Journal of cardiovascular pharmacology.

[31]  L. Thijs,et al.  Plasma endothelin levels are increased during septic shock , 1992, Critical care medicine.

[32]  D. Brackett,et al.  Release of vasoactive hormones and circulatory changes in shock. , 1983, Circulatory shock.

[33]  P. Suter,et al.  Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. , 1991, Annals of surgery.

[34]  J. Becquemin,et al.  Aortic surgery: effect of clonidine on intraoperative catecholaminergic and circulatory stability , 1990, Acta anaesthesiologica Scandinavica.

[35]  S. Baker,et al.  The injury severity score: an update. , 1976, The Journal of trauma.

[36]  C. Mitaka,et al.  Circulating endothelin-1 concentrations in acute respiratory failure. , 1993, Chest.

[37]  E. Ruokonen,et al.  Blood Flow and Adrenergic Drugs in Septic Shock , 1991 .

[38]  H. Koyama,et al.  PLASMA ENDOTHELIN LEVELS IN PATIENTS WITH URAEMIA , 1989, The Lancet.

[39]  J. Marshall,et al.  Multiple-organ-failure syndrome. , 1986, Archives of surgery.